Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Duffey

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|March 19, 1987
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's diseaseD W Blayney, D L Longo, R C Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1991
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatmentD L Longo, A Russo, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and managementA Surbone, D L Longo, V T DeVita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapyD L Longo, P L Duffey, E S Jaffe, et al.
Clinical Immunology (Orlando, Fla.)|March 18, 1999
Conditioned immune response to interferon-gamma in humansD L Longo, P L Duffey, W C Kopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 1991
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPPD L Longo, P L Duffey, V T DeVita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapyD L Longo, E Glatstein, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trialD L Longo, E Glatstein, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cureD L Longo, P L Duffey, R C Young, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|March 19, 1987
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's diseaseD W Blayney, D L Longo, R C Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1991
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatmentD L Longo, A Russo, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and managementA Surbone, D L Longo, V T DeVita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapyD L Longo, P L Duffey, E S Jaffe, et al.
Clinical Immunology (Orlando, Fla.)|March 18, 1999
Conditioned immune response to interferon-gamma in humansD L Longo, P L Duffey, W C Kopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 1991
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPPD L Longo, P L Duffey, V T DeVita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapyD L Longo, E Glatstein, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trialD L Longo, E Glatstein, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cureD L Longo, P L Duffey, R C Young, et al.
Pageof 3